At the starting dose of 2 mg per week, one vial lasts five weeks
Follow any personalized aftercare advice from your healthcare professional
doi: 10.3389/fimmu.2026.1701767 Received 09 September 2025 Revised 16 January 2026 Accepted 19 January 2026 Published 06 February 2026 Volume 17 - 2026 Edited by Uzma Saqib, Devi Ahilya University, India Reviewed by Eduard Yakubov, Paracelsus Medical Private University, Germany Hongjian Pu, University of Pittsburgh, United States Monika Pandey, Devi Ahilya Vishwavidyalaya, India Updates Copyright 2026 Quan, Liu, Zhang, Li, He, Wang, Huang, Zhou, Han and Fan
Sterile syringes and needles with appropriate gauge and length based on the injection site
Biogenic Foods Retatru and Cagrilintide - Research Peptide (compare to Retatrutide) SKU: Reta/Cag-12.5MG/2.5MG Weight: 2.00 Ounces Description Description CAS Number: N/A (research blend) Molecular Formula: N/A (research blend) Molecular Weight: N/A (research blend) Form: Lyophilized Powder Quantity: 12.5mg/2.5mg & 15mg/5mg vial Purity: 98% (HPLC Verified) Dosing Information Retatru is typically administered once weekly via subcutaneous injection, with doses ranging from 1 mg to 12 mg depending on clinical indication and patient response
